Alzheimer’s disease (AD) and type 2 diabetes mellitus (DM), both of which are characterized by increased prevalence with aging, have considerable overlap in their risk factors, comorbidities and pathophysiological mechanisms including insulin resistance. This evidence concerns the gene INS and type 2 diabetes mellitus.